Latest Boston Scientific Corporation Stories
Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval MARLBOROUGH, Mass., Sept.
Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life MARLBOROUGH, Mass., Sept.
No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year MARLBOROUGH, Mass., Sept.
Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease MARLBOROUGH, Mass., Sept.
MARLBOROUGH, Mass., Sept.
MARLBOROUGH, Mass., Sept. 2, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG.
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug.
Large, Prospective, Multi-National Study Examines Management of Benign Biliary Strictures with Fully Covered Self-Expanding Metal Stents after Extended Indwell MARLBOROUGH, Mass., Aug.
MALBOROUGH, Mass., Aug.
Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass.
- The word or words serving to define another word or expression, as in a dictionary entry.